These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 28359815

  • 21. Self-crosslinkable and intracellularly decrosslinkable biodegradable micellar nanoparticles: A robust, simple and multifunctional nanoplatform for high-efficiency targeted cancer chemotherapy.
    Zou Y, Fang Y, Meng H, Meng F, Deng C, Zhang J, Zhong Z.
    J Control Release; 2016 Dec 28; 244(Pt B):326-335. PubMed ID: 27245309
    [Abstract] [Full Text] [Related]

  • 22. A small molecule nanodrug consisting of amphiphilic targeting ligand-chemotherapy drug conjugate for targeted cancer therapy.
    Mou Q, Ma Y, Zhu X, Yan D.
    J Control Release; 2016 May 28; 230():34-44. PubMed ID: 27040815
    [Abstract] [Full Text] [Related]

  • 23. Glycyrrhetinic acid-modified poly(ethylene glycol)-b-poly(gamma-benzyl l-glutamate) micelles for liver targeting therapy.
    Huang W, Wang W, Wang P, Tian Q, Zhang C, Wang C, Yuan Z, Liu M, Wan H, Tang H.
    Acta Biomater; 2010 Oct 28; 6(10):3927-35. PubMed ID: 20438873
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Self-assembly and liver targeting of sulfated chitosan nanoparticles functionalized with glycyrrhetinic acid.
    Tian Q, Wang XH, Wang W, Zhang CN, Wang P, Yuan Z.
    Nanomedicine; 2012 Aug 28; 8(6):870-9. PubMed ID: 22100756
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. In vitro and in vivo effect of hyaluronic acid modified, doxorubicin and gallic acid co-delivered lipid-polymeric hybrid nano-system for leukemia therapy.
    Shao Y, Luo W, Guo Q, Li X, Zhang Q, Li J.
    Drug Des Devel Ther; 2019 Aug 28; 13():2043-2055. PubMed ID: 31388296
    [Abstract] [Full Text] [Related]

  • 30. Contribution of carboxyl modified chiral mesoporous silica nanoparticles in delivering doxorubicin hydrochloride in vitro: pH-response controlled release, enhanced drug cellular uptake and cytotoxicity.
    Li J, Du X, Zheng N, Xu L, Xu J, Li S.
    Colloids Surf B Biointerfaces; 2016 May 01; 141():374-381. PubMed ID: 26878288
    [Abstract] [Full Text] [Related]

  • 31. Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.
    Fan L, Li F, Zhang H, Wang Y, Cheng C, Li X, Gu CH, Yang Q, Wu H, Zhang S.
    Biomaterials; 2010 Jul 01; 31(21):5634-42. PubMed ID: 20430433
    [Abstract] [Full Text] [Related]

  • 32. Low molecular weight heparin-based reduction-sensitive nanoparticles for antitumor and anti-metastasis of orthotopic breast cancer.
    Sun H, Cao D, Liu Y, Wang H, Ke X, Ci T.
    Biomater Sci; 2018 Jul 24; 6(8):2172-2188. PubMed ID: 29942949
    [Abstract] [Full Text] [Related]

  • 33. Delivery of miR-375 and doxorubicin hydrochloride by lipid-coated hollow mesoporous silica nanoparticles to overcome multiple drug resistance in hepatocellular carcinoma.
    Xue H, Yu Z, Liu Y, Yuan W, Yang T, You J, He X, Lee RJ, Li L, Xu C.
    Int J Nanomedicine; 2017 Jul 24; 12():5271-5287. PubMed ID: 28769563
    [Abstract] [Full Text] [Related]

  • 34. Effective co-delivery of doxorubicin and curcumin using a glycyrrhetinic acid-modified chitosan-cystamine-poly(ε-caprolactone) copolymer micelle for combination cancer chemotherapy.
    Yan T, Li D, Li J, Cheng F, Cheng J, Huang Y, He J.
    Colloids Surf B Biointerfaces; 2016 Sep 01; 145():526-538. PubMed ID: 27281238
    [Abstract] [Full Text] [Related]

  • 35. Folate-modified doxorubicin-loaded nanoparticles for tumor-targeted therapy.
    Wu G, Wang Z, Bian X, Du X, Wei C.
    Pharm Biol; 2014 Aug 01; 52(8):978-82. PubMed ID: 25017652
    [Abstract] [Full Text] [Related]

  • 36. Lipopepsomes: A novel and robust family of nano-vesicles capable of highly efficient encapsulation and tumor-targeted delivery of doxorubicin hydrochloride in vivo.
    Qiu M, Sun H, Meng F, Cheng R, Zhang J, Deng C, Zhong Z.
    J Control Release; 2018 Feb 28; 272():107-113. PubMed ID: 29355618
    [Abstract] [Full Text] [Related]

  • 37. Doxorubicin-Loaded Carbon Dots Lipid-Coated Calcium Phosphate Nanoparticles for Visual Targeted Delivery and Therapy of Tumor.
    Zhang J, Zhang H, Jiang J, Cui N, Xue X, Wang T, Wang X, He Y, Wang D.
    Int J Nanomedicine; 2020 Feb 28; 15():433-444. PubMed ID: 32021189
    [Abstract] [Full Text] [Related]

  • 38. Dual-Ligand-Functionalized Liposomes Based on Glycyrrhetinic Acid and cRGD for Hepatocellular Carcinoma Targeting and Therapy.
    Qiu M, Wang J, Bai J, Li X, Tian C, Liu Z, Zheng C, Clark AR, Cheng X, Liao X, Wu S, Lee RJ, Zhou X.
    Mol Pharm; 2023 Apr 03; 20(4):1951-1963. PubMed ID: 36952242
    [Abstract] [Full Text] [Related]

  • 39. A low-molecular-weight heparin-coated doxorubicin-liposome for the prevention of melanoma metastasis.
    Chen Y, Peng J, Han M, Omar M, Hu D, Ke X, Lu N.
    J Drug Target; 2015 May 03; 23(4):335-46. PubMed ID: 25541466
    [Abstract] [Full Text] [Related]

  • 40. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
    Zhang Q, Zhao H, Li D, Liu L, Du S.
    Colloids Surf B Biointerfaces; 2017 Jan 01; 149():138-145. PubMed ID: 27750088
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.